Free Trial

IBEX (NASDAQ:IBEX) Insider Sells $51,460.00 in Stock

IBEX logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • IBEX insider Christina O’Connor sold 1,000 shares for $51,460 at $51.46 each, reducing her stake by 2.6%; she retained 37,424 shares.
  • IBEX shares rose to $52.23, near their 12-month high, after the company reported quarterly earnings of $1.10 per share and revenue of $175.23 million, both above analyst expectations.
  • Analysts’ consensus rating is Hold, with an average price target of $44.50; the article also notes broader insider selling, including sales by six insiders.
  • Five stocks we like better than IBEX.

IBEX Limited (NASDAQ:IBEX - Get Free Report) insider Christina O'Connor sold 1,000 shares of the business's stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $51.46, for a total value of $51,460.00. Following the transaction, the insider owned 37,424 shares of the company's stock, valued at $1,925,839.04. This trade represents a 2.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Christina Al Trofimuk-O'connor also recently made the following trade(s):

  • On Wednesday, September 16th, Christina O'Connor sold 2,376 shares of IBEX stock. The stock was sold at an average price of $39.34, for a total value of $93,471.84.
  • On Tuesday, September 15th, Christina O'Connor sold 7,500 shares of IBEX stock. The shares were sold at an average price of $40.30, for a total value of $302,250.00.

IBEX Price Performance

Shares of IBEX traded up $1.95 during trading hours on Tuesday, reaching $52.23. 432,801 shares of the company's stock traded hands, compared to its average volume of 124,838. IBEX Limited has a twelve month low of $25.94 and a twelve month high of $52.29. The business's fifty day simple moving average is $43.25 and its two-hundred day simple moving average is $34.57. The firm has a market capitalization of $696.75 million, a price-to-earnings ratio of 15.83 and a beta of 0.74.

IBEX (NASDAQ:IBEX - Get Free Report) last released its earnings results on Thursday, November 5th. The company reported $1.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.20. IBEX had a return on equity of 28.96% and a net margin of 7.19%. The firm had revenue of $175.23 million during the quarter, compared to the consensus estimate of $169.31 million.

Hedge Funds Weigh In On IBEX

A number of hedge funds have recently modified their holdings of the stock. Lazard Asset Management LLC raised its holdings in shares of IBEX by 55.2% during the first quarter. Lazard Asset Management LLC now owns 89,150 shares of the company's stock worth $2,391,000 after acquiring an additional 31,697 shares in the last quarter. Globeflex Capital L P purchased a new position in IBEX in the second quarter valued at about $3,112,000. Tieton Capital Management LLC purchased a new position in IBEX in the second quarter valued at about $8,353,000. Watershed Asset Management L.L.C. acquired a new position in IBEX in the 1st quarter worth about $453,000. Finally, Dimensional Fund Advisors LP increased its position in IBEX by 7.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 358,191 shares of the company's stock worth $9,607,000 after purchasing an additional 24,942 shares during the last quarter. 81.24% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about IBEX

Here are the key news stories impacting IBEX this week:

  • Positive Sentiment: IBEX CEO Bob Dechant and CFO Taylor Greenwald are scheduled to present at the RBC 2026 Global TIMT Conference on November 17. The event offers an opportunity to discuss the business and its outlook, though no new financial guidance was announced. Conference announcement
  • Neutral Sentiment: A short-interest report lists zero shares sold short as of November 10, despite characterizing short interest as having increased. If the zero figure is accurate, it indicates little reported short positioning; the conflicting description makes the update difficult to interpret.
  • Negative Sentiment: RBC raised its price target to $45 from $40 but maintained a “sector perform” rating. The new target is below the recent share price, implying potential downside and suggesting the analyst sees limited near-term upside at current levels.
  • Negative Sentiment: Six IBEX insiders, including CEO Dechant, reported share sales totaling about 31,200 shares. Dechant’s 5,000-share transaction was made under a pre-arranged Rule 10b5-1 plan, and sellers retained shares after their trades; nonetheless, the cluster of sales could weigh on sentiment. CEO filing Insider filing Insider filing Insider filing Insider filing Director filing

Analyst Ratings Changes

IBEX has been the subject of several research analyst reports. Robert W. Baird upped their price target on shares of IBEX from $40.00 to $44.00 and gave the company a "neutral" rating in a research report on Monday, September 28th. Weiss Ratings raised shares of IBEX from a "buy (b-)" rating to a "buy (b)" rating in a research note on Monday, October 12th. Royal Bank Of Canada increased their price target on shares of IBEX from $40.00 to $45.00 and gave the stock a "sector perform" rating in a research report on Tuesday. Finally, Wall Street Zen upgraded shares of IBEX from a "buy" rating to a "strong-buy" rating in a report on Saturday. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $44.50.

Check Out Our Latest Stock Analysis on IBEX

About IBEX

(Get Free Report)

IBEX Limited NASDAQ: IBEX is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services. The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.

See Also

Insider Buying and Selling by Quarter for IBEX (NASDAQ:IBEX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in IBEX Right Now?

Before you consider IBEX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IBEX wasn't on the list.

While IBEX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines